Lenalid
Lenalid (Lenalidomide 5/10/25 mg) — Natco IMiD for multiple myeloma. Pregnancy black-box; mandatory thromboprophylaxis with corticosteroid combinations.
✓ Medisinsk vurdert av Morgan Ellis — Farmasøytisk forsker · 8 års erfaring · Sist gjennomgått: mai 2026
Kort svar
Lenalid — Lenalidomide 5/10/25 mg (Natco Pharma). Immunomodulatory drug (IMiD) for multiple myeloma (newly diagnosed and relapsed/refractory), 5q-myelodysplastic syndrome, and mantle cell lymphoma. Modern IMiD with greater potency and fewer neuropathy/sedation side effects than thalidomide.
Hva du får med MedsBase:
- WHO-GMP-sertifisert produsent
- Diskré emballasje i vanlig konvolutt
- Verdensomspennende levering
- Vurdert av over 1 400 kunder (les anmeldelser)
📦 Reshipment Assurance: hvis din ordre ikke har kommet frem 20 virkedager etter forsendelse, sender vi den på nytt uten ekstra kostnad. Les policyen.
Hvorfor bestille fra MedsBase
Lenalid ships from a WHO-GMP certified manufacturer in plain packaging, billed through a regulated payment processor (the statement descriptor reads a regulated card-payment processor — never MedsBase or any medication name). Every order carries our 20-business-day Reshipment Assurance.
⚠️ Specialist-supervised cancer therapy — this medication is started, monitored, and stopped by an oncologist or haematologist. Dosing depends on tumour type, stage, body surface area, organ function, and concomitant therapy. Self-treatment is not appropriate; the information below is educational and supports informed conversations with your specialist.
All IMiDs are severely teratogenic (thalidomide most notoriously — phocomelia). Mandatory pregnancy-prevention programme (REMS/iCare equivalent): pregnancy testing before, during, and after; two effective contraceptive methods; counselling for both partners; no blood donation during therapy or for 4 weeks after. Even one dose during pregnancy can cause severe malformations.
IMiDs carry significantly elevated risk of deep vein thrombosis and pulmonary embolism, especially in combination with corticosteroids or doxorubicin. Mandatory thromboprophylaxis: low-dose aspirin (low-risk), or LMWH/warfarin/DOAC (higher-risk patients). Specialist-determined.
All IMiDs cause myelosuppression — neutropenia, thrombocytopenia, anaemia. Weekly FBC during initiation; monthly maintenance. Renal dose adjustment (lenalidomide especially — significant renal accumulation).
Vanlige spørsmål
When is this used?
Immunomodulatory drug (IMiD) for multiple myeloma (newly diagnosed and relapsed/refractory), 5q-myelodysplastic syndrome, and mantle cell lymphoma. Modern IMiD with greater potency and fewer neuropathy/sedation side effects than thalidomide.
How is it taken?
Once daily, typically in cycles (e.g., 21 days on, 7 days off for lenalidomide). Specific dose and schedule are myeloma-protocol-specific (Rd, RVd, KRd, etc.). Specialist-determined by tumour response and tolerability.
Pregnancy prevention?
Mandatory programme: monthly pregnancy tests, two effective contraceptive methods, partner contraception, counselling. Even one dose during pregnancy causes severe malformations. No blood donation during therapy or for 4 weeks after stopping.
Common side effects?
IMiD class: VTE, fatigue, rash, GI (constipation, diarrhoea), myelosuppression. Lenalidomide: less neuropathy than thalidomide. Pomalidomide: often better tolerated than thalidomide; renal-friendly. Thalidomide: peripheral neuropathy, sedation.
Legemiddelinteraksjoner?
Anticoagulants — adjust based on VTE prophylaxis strategy. Digoxin levels may rise. Erythropoietin agents + IMiD — increased thrombosis risk; use only with mandatory thromboprophylaxis.
Renal monitoring?
Lenalidomide: dose-adjust by CrCl (significant renal accumulation). Pomalidomide: less renal effect but still monitor. Thalidomide: renally cleared metabolite — monitor renal function.
Hva om jeg glemmer en dose?
Take when you remember if <12 hours late; otherwise skip and resume — do not double up. Notify oncology team if multiple doses missed.
Vaksinasjon?
Inactivated vaccines OK; live vaccines contraindicated during IMiD therapy. Optimise vaccinations before starting if possible.
Long-term complications?
IMiD therapy: secondary primary malignancies (especially with extended use), cumulative VTE risk, neuropathy (thalidomide especially).
When is treatment stopped?
Specialist-determined: response duration, toxicity, planned treatment break, transition to maintenance therapy. IMiD maintenance therapy is now standard in myeloma — typically lenalidomide post-autologous stem cell transplant continued for 2-3 years or until intolerance.
Other Cancer Medications
- Xeloda — capecitabine 500 mg — oral 5-FU prodrug for breast/colorectal/gastric cancers
- Altraz — anastrozole 1 mg — aromatase inhibitor for post-menopausal breast cancer
- Xbira — abiraterone 250 mg — CYP17 inhibitor for metastatic prostate cancer
- Zoldria — zoledronic acid IV — for bone metastases and hypercalcaemia
- Actorise — darbepoetin alfa — for chemotherapy-induced anaemia
More options in Anti Cancer Medication
Rangert etter nylig bestillingsvolum på MedsBase — hva andre kunder i denne kategorien velger.
| Styrke | 5 mg, 10 mg, 25 mg |
|---|---|
| Antall | 30 Kapsel/er, 60 Kapsel/er, 90 Kapsel/er |
| Farmasøytisk form | Kapsel/er |
| Produsent | Natco Pharma |
| Behandling | Multiple myeloma, Lepra reaction |
| Generisk merke | Lenalidomide |
Lenalid
Spørsmål og svar
Lenalid
Relaterte produkter
Anmeldelser
Det er ingen anmeldelser ennå